CIK 0001035422 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
CTT PHARMACEUTICAL HOLDINGS, INC.
Sign in to watch- Ticker
- CTTH
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- FL
- Entity type
- operating
- EIN
- 113763974
- Phone
- 813-606-0060
- Business address
- 1646 W. SNOW AVE SUITE 138, TAMPA, FL, 33606
- Former names
- Mindesta Inc., INDUSTRIAL MINERALS INC, PNW CAPITAL INC, WINCHESTER MINING CORP
- Open-market buys, last 90 days
- $4,917
- in 15 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$4,917. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-07 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +9,500 | $0.04 | $380 | 4,167,388 |
| 2024-05-02 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +4,388 | $0.03 | $136 | 4,157,888 |
| 2023-03-27 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +8,700 | $0.02 | $191 | 883,500 |
| 2023-03-20 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Grant or award | +500,000 | $0.02 | $10K | 1,383,500 |
| 2023-03-03 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +3,840 | $0.04 | $134 | 874,800 |
| 2023-02-08 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +4,960 | $0.04 | $174 | 870,960 |
| 2023-01-30 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +9,000 | $0.03 | $225 | 866,000 |
| 2023-01-25 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +61,695 | $0.02 | $1K | 857,000 |
| 2022-08-18 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +500,000 | $0.02 | $10K | 1,883,500 |
| 2022-02-18 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +500,000 | $0.02 | $10K | 2,383,500 |
| 2014-05-22 | Bowes Gregory B. CEO/CFO | Other acquisition | +10,000,000 | $0.01 | $100K | 10,570,000 |
| 2014-05-22 | Bowes Gregory B. CEO/CFO | Other disposition | −500,000 | $0.01 | $5K | 10,070,000 |
| 2012-03-15 | Zapanta Albert C Director | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2012-03-15 | Perkins Douglas G. Director | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2012-03-15 | Bowes Gregory B. CEO and CFO | Grant or award · Employee Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2012-03-15 | Birge William Campbell Director | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2012-01-04 | Birge William Campbell Director | Option exercise | +112,500 | $0.30 | $34K | 402,250 |
| 2012-01-04 | Birge William Campbell Director | Option exercise · Employee Stock Option (right to buy) | −112,500 | 0 | ||
| 2011-12-22 | Bowes Gregory B. CEO and CFO | Option exercise | +225,000 | $0.30 | $68K | 575,000 |
| 2011-12-22 | Bowes Gregory B. CEO and CFO | Option exercise · Employee Stock Option (right to buy) | −225,000 | 0 |
Page 4 of 6 · 110 trades